FundedIQ
Biotechnology

InvenireX: Funding, Investors & Team (Oct 2026)

InvenireX is a biotech company that provides molecular diagnostics services.

www.invenirex.co.uk LinkedIn Newcastle Upon Tyne, United Kingdom 1-10 employees
Biotechnology Health Diagnostics
Total raised
$3.3M
Rounds
2
Latest
Seed
Nov 2025

InvenireX has raised $3.3M across 2 funding rounds on record, the most recent a Seed of $2.6M announced in Nov 2025.

That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

InvenireX Company Profile and Key Stats

Total funding raised
$3.3M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Seed
$2.6M in Nov 2025
Employees
1-10
reported band
Headquarters
Newcastle Upon Tyne, United Kingdom

Latest funding round on record: Nov 2025.

InvenireX Funding Rounds

Date
Round
Amount
Seed
$2.6M
Undisclosed round
$640k

InvenireX raised $640k in an undisclosed round announced in Mar 2024.

1.7 years later, a Seed of $2.6M was announced in Nov 2025.

InvenireX Founders and Leadership Team

Name
Role
Contact
Dan Todd
Founder
—
Dr. Dan Todd
—
Locked

Contact details for the InvenireX team: 1 of 2 have an email address on file, 1 has a LinkedIn profile.

Start 14-day free trial →

InvenireX Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
5,352
$4.1M
17,054
$3.1M

InvenireX's latest round of $2.6M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like InvenireX in Biotechnology and Newcastle Upon Tyne

Companies Similar to InvenireX

R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…

Series A $3.0M

The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…

Undisclosed round $9.3M

Argonaute RNA company research projects build on existing intellectual property.

Undisclosed round $1.8M

An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…

Undisclosed round $1.8M

ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…

Undisclosed round $23.3M

Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…

Series A $33.6M

Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…

Undisclosed round $3.5M

Concert Bio helps businesses create optimal microbial communities.

Undisclosed round $130k

RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…

Series A $113M

N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…

Undisclosed round $3.6M

Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…

Undisclosed round $3.0M

Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.

Series A $32.5M

InvenireX Funding FAQs

What does InvenireX do?

InvenireX is a biotech company that provides molecular diagnostics services.

How much funding has InvenireX raised?

InvenireX has raised $3.3M across 2 rounds on record. The most recent is a Seed of $2.6M announced in Nov 2025.

When did InvenireX last raise funding?

InvenireX's most recent funding round on record is a Seed of $2.6M, announced in Nov 2025.

Who founded InvenireX?

FundedIQ lists Dan Todd (Founder) at InvenireX.

Where is InvenireX headquartered?

InvenireX is based in Newcastle Upon Tyne, United Kingdom.

How many employees does InvenireX have?

InvenireX is in the 1-10 employee band.

How does InvenireX's funding compare to other Biotechnology startups?

InvenireX's latest round of $2.6M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's InvenireX Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for InvenireX is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.